BACKGROUND:
This pilot study investigated the effect of sufentanil titration by 3 different analgesia monitoring devices or clinical signs during general anesthesia.
METHODS:
Forty-eight patients undergoing radical retropubic prostatectomy with sevoflurane/sufentanil anesthesia were randomly assigned into 4 groups and received sufentanil guided either by 1 of 3 analgesia monitoring devices (Surgical Pleth Index [SPI], Pupillary Pain Index [PPI], Nociception Level [NoL]) or by clinical judgment (control). The primary end point was intraoperative sufentanil consumption. Adrenocorticotropic hormone (ACTH) and cortisol were measured at 4 time points during the day of surgery. Data were analyzed by Kruskal–Wallis and Mann–Whitney U tests and by mixed model and area under the curve (AUC) analyses for group comparisons and time effects of stress hormones.
RESULTS:
The total amount of sufentanil administration (μg·kg−1·minute−1·10−3) differed between the groups (median [quartiles]: control = 5.6 [4.4–6.4], SPI = 7.2 [4.8–8.4], PPI = 2.0 [1.8–2.9], NoL = 3.8 [3.3–5.1]; PPI versus SPI, −5.1 [−6.6 to −1.3], P < .001; NoL versus SPI, −3.0 [−5.2 to 0.2], P = .024; control versus SPI, −1.6 [−3.7 to 1.7], P = .128; NoL versus PPI, 1.7 [0.6–3.4], P < .001; control versus PPI, 3.4 [2.0–4.6], P < .001; control versus NoL, 1.6 [−0.2 to 3.3], P = .017) (Hodges–Lehmann estimator [99% confidence interval {CI}], P values). The AUC analysis indicated differences among groups in cumulative ACTH levels (ng·liter−1·minute, natural logarithm (ln)-transformed data) of NoL versus PPI (−1.079 [−1.950 to −0.208], P = .001) and PPI versus SPI (1.192 [0.317–2.068], P= .001), as well as differences in cortisol levels (µg·liter−1·minute) for PPI versus SPI (46,710 [21,145–72,274], P < .001), NoL versus SPI (27,645 [3163–52,126], P = .003), and control versus SPI (31,824 [6974–56,675], P = .001) (differences in means [99% CI], P value). Secondary end points (postoperative recovery, pain level, and analgesia medication) showed no differences.
CONCLUSIONS:
The type of analgesia nociception monitoring affected the total amount of sufentanil administered. Lower sufentanil doses in the PPI group were associated with an increased endocrine stress response. Titration by SPI caused no opioid reduction compared to the control but was associated with a reduced endocrine stress response.
See Article, p 1261
KEY POINTS
- Question: Does titration of an intraoperative opioid by the 3 different analgesia monitoring indices (Surgical Pleth Index [SPI], Pupillary Pain Index [PPI], and Nociception Level [NoL]) or by clinical signs in the control group lead to different amounts of sufentanil administered during radical retropubic prostatectomy?
- Findings: The type of nociception monitoring affected sufentanil consumption, and lower levels of opioids were associated with higher levels of stress hormones.
- Meaning: The monitor readings and target ranges did not seem to represent the same nociception–antinociception state, and lower doses of sufentanil were associated with more intraoperative stress as reflected by the elevated adrenocorticotropic hormone (ACTH) and cortisol concentrations.
Leave a Reply
You must be logged in to post a comment.